Literature DB >> 21895398

Ovarian cancer: origin and factors involved in carcinogenesis with potential use in diagnosis, treatment and prognosis of the disease.

L Zavesky1, N Jancarkova, M Kohoutova.   

Abstract

Ovarian cancer representing the most lethal gynecologic malignancy escapes from the efforts to manage the disease. We reviewed the current state of the research considering three main concepts on origin of ovarian cancer including epithelial-mesenchymal transition, secondary origin from Müllerian system and cancer stem cell hypothesis. Cytogenetic and molecular characteristics of ovarian cancer are focused particularly on microRNA expression studies revealing huge potential in recent years, although other transcriptomic, proteomic, epigenetic, epidemiologic and immunological factors are touched upon, too. Routine and investigated diagnostic and treatment methods are outlined and several factors revealed to be associated with prognosis of the disease. Despite the huge progress on elucidating factors involved in ovarian cancer carcinogenesis, still remains urgent need to improve both the diagnostics as well as the treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21895398     DOI: 10.4149/neo_2011_06_457

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  2 in total

1.  Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.

Authors:  Luděk Záveský; Eva Jandáková; Radovan Turyna; Lucie Langmeierová; Vít Weinberger; Lenka Záveská Drábková; Martina Hůlková; Aleš Hořínek; Daniela Dušková; Jaroslav Feyereisl; Luboš Minář; Milada Kohoutová
Journal:  Pathol Oncol Res       Date:  2015-04-01       Impact factor: 3.201

2.  Enhanced efficacy and specificity of epithelial ovarian carcinogenesis by embedding a DMBA-coated cloth strip in the ovary of rat.

Authors:  Yiping Huang; Wei Jiang; Yisheng Wang; Yufang Zheng; Qing Cong; Congjian Xu
Journal:  J Ovarian Res       Date:  2012-09-03       Impact factor: 4.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.